Xenikos Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Xenikos General Information
Description
Developer of an immune-reset therapy designed to treat severe immune-related conditions. The company's therapy aims to restore immune system function and has been studied in patients with steroid-refractory acute graft-versus-host disease, with potential applications in organ rejection and autoimmune diseases, enabling patients and healthcare providers to access treatment options when standard steroid therapy fails.
Contact Information
Website
www.xenikos.comCorporate Office
- Wilhelminasingel 14
- 6524 AL Nijmegen
- Netherlands
Corporate Office
- Wilhelminasingel 14
- 6524 AL Nijmegen
- Netherlands
Xenikos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 04-Apr-2026 | Completed | Clinical Trials - Phase 3 | |||
| 6. Grant | 05-Oct-2022 | Completed | Clinical Trials - Phase 3 | |||
| 5. Later Stage VC | 02-Sep-2021 | Completed | Clinical Trials - Phase 3 | |||
| 4. Later Stage VC (Series B) | 15-May-2018 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 03-Jan-2017 | Completed | Pre-Clinical Trials | |||
| 2. Later Stage VC | 14-Oct-2016 | $2.24M | $9.1M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A) | 19-Jun-2012 | $6.9M | $6.9M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Xenikos Comparisons
Industry
Financing
Details
Xenikos Competitors (52)
One of Xenikos’s 52 competitors is Neurona Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Baliopharm | Venture Capital-Backed | Basel, Switzerland | ||||
| NeuroNascent | Venture Capital-Backed | Clarksville, MD | ||||
| Enterome | Venture Capital-Backed | Paris, France |
Xenikos Patents
Xenikos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201717966-D0 | Immunotoxins, formulations thereof and their use in medicine | Inactive | 31-Oct-2017 | ||
| US-11447548-B2 | Immunotoxins, formulations thereof and their use in medicine | Active | 31-Oct-2017 | ||
| US-20200407443-A1 | Immunotoxins, formulations thereof and their use in medicine | Active | 31-Oct-2017 | ||
| WO-2019086534-A1 | Immunotoxins, formulations thereof and their use in medicine | Inactive | 31-Oct-2017 | ||
| GB-201617487-D0 | Reducing viral infection and/or viral reactivation during immunotherapy | Inactive | 14-Oct-2016 |
Xenikos Signals
Xenikos Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Veloxis Pharmaceuticals | Corporation | Minority | ||
| Medicxi Ventures (UK) | Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority | ||
| Stitching Participatie Xenikos | Corporation | Minority |
Xenikos FAQs
-
When was Xenikos founded?
Xenikos was founded in 2009.
-
Where is Xenikos headquartered?
Xenikos is headquartered in Nijmegen, Netherlands.
-
What is the size of Xenikos?
Xenikos has 17 total employees.
-
What industry is Xenikos in?
Xenikos’s primary industry is Drug Discovery.
-
Is Xenikos a private or public company?
Xenikos is a Private company.
-
What is Xenikos’s current revenue?
The current revenue for Xenikos is .
-
How much funding has Xenikos raised over time?
Xenikos has raised $86.2M.
-
Who are Xenikos’s investors?
European Innovation Council, Veloxis Pharmaceuticals, Medicxi Ventures (UK), RA Capital Management, and Stitching Participatie Xenikos are 5 of 7 investors who have invested in Xenikos.
-
Who are Xenikos’s competitors?
Neurona Therapeutics, AnTolRx, Baliopharm, NeuroNascent, and Enterome are some of the 52 competitors of Xenikos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process